首页> 中文期刊>南昌大学学报(医学版) >醒脑静联合纳洛酮对高血压脑出血患者 GCS、ADL 指标的影响

醒脑静联合纳洛酮对高血压脑出血患者 GCS、ADL 指标的影响

     

摘要

ABSTRACT:Objective To investigate the effects of Xingnaojing combined with naloxone on scores of Glasgow Coma Scale (GCS)and activities of daily living (ADL)in patients with hyper-tensive cerebral hemorrhage.Methods Sixty patients with hypertensive cerebral hemorrhage were randomly treated with naloxone alone (control group,n=30)or in combination with Xing-naojing (observation group,n = 30)between October 2013 and October 2014.GCS and ADL scores were measured in both groups.Results Compared with control group,neurological impair-ment was relieved,ADL score was increased and hematoma volume was reduced in observation group (P <0.05).Conclusion The combined treatment with Xingnaojing and naloxone can obvi-ously improve GCS and ADL scores and significantly decrease the mortality in patients with hy-pertensive cerebral hemorrhage.%目的:探讨醒脑静联合纳洛酮对高血压脑出血患者格拉哥斯评分法(GCS)、日常生活能力量表(ADL)的影响。方法选取2013年10月至2014年10月收治的60例高血压脑出血患者,按随机数字表法分为观察组和对照组,每组30例。观察组采取醒脑静联合纳洛酮进行治疗,对照组单独使用纳洛酮,观察2组患者治疗前后 GCS 及ADL 指标的变化。结果观察组患者神经功能缺损情况显著少于对照组(P <0.05);观察组患者生活能力评分显著高于对照组(P <0.05);观察组患者治疗后血肿量显著少于对照组(P <0.05)。结论醒脑静联合纳洛酮对高血压脑出血患者进行治疗效果显著,有利于改善患者神经缺损功能评分及日常生活能力评分,降低患者死亡率。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号